{
     "PMID": "15985260",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050912",
     "LR": "20131121",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "517",
     "IP": "3",
     "DP": "2005 Jul 11",
     "TI": "In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.",
     "PG": "165-73",
     "AB": "This study determined the in vitro functional profile of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinon e monomethanesulfonate (OPC-14523) at rat and human serotonin (5-HT) 5-HT1A receptors and binding affinity of OPC-14523 at human frontocortical 5-HT1A receptors. OPC-14523 (1 microM) increased guanosine-5'-O-(3-[35S]thio)-triphosphate ([35S]GTPgammaS) binding to 5-HT1A receptor-containing regions of rat brain tissue sections (approximately 53% of the effect of 1 microM (+)8-hydroxy-2-(di-n-propylamino)tetralin ((+)8-OH-DPAT) that were blocked by the selective 5-HT1A receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamid e (WAY-100635). OPC-14523 also behaved as a partial agonist in its stimulation of [35S]GTPgammaS binding to membranes from rat hippocampus (pEC50=7.60+/-0.23, Emax=41.1% of the effect of 10 microM (+)8-OH-DPAT), human frontal cortex (pEC50=7.89+/-0.08; Emax=64% of the effect of 10 microM (+)8-OH-DPAT), and Chinese Hamster Ovary cells expressing cloned human 5-HT1A receptors (pEC50=8.0+/-0.11; Emax=85.5% of the effect of 10 microM 5-HT), and all of these effects of OPC-14523 were blocked by WAY-100635. Taken together, these data support the development of OPC-14523 as an antidepressant whose mechanism of action involves potent partial agonist activity at 5-HT1A receptors.",
     "FAU": [
          "Jordan, Shaun",
          "Chen, Ruoyan",
          "Koprivica, Vuk",
          "Hamilton, Ronald",
          "Whitehead, Richard E",
          "Tottori, Katsura",
          "Kikuchi, Tetsuro"
     ],
     "AU": [
          "Jordan S",
          "Chen R",
          "Koprivica V",
          "Hamilton R",
          "Whitehead RE",
          "Tottori K",
          "Kikuchi T"
     ],
     "AD": "Department of Neuroscience Research, Otsuka Maryland Medicinal Laboratories, 9900 Medical Center Drive, Rockville, MD 20850, USA. shaunj@otsuka.com",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0",
          "(1-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-3,4-dihydro-5-methoxy-2(1H)-quino",
          "linone)",
          "0 (Antidepressive Agents)",
          "0 (Piperazines)",
          "0 (Pyridines)",
          "0 (Quinolones)",
          "0 (Serotonin 5-HT1 Receptor Agonists)",
          "0 (Serotonin 5-HT1 Receptor Antagonists)",
          "0 (Serotonin Antagonists)",
          "0 (Serotonin Receptor Agonists)",
          "0 (Sulfur Radioisotopes)",
          "112692-38-3 (Receptor, Serotonin, 5-HT1A)",
          "115338-32-4 (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine)",
          "37589-80-3 (Guanosine 5'-O-(3-Thiotriphosphate))",
          "71IH826FEG",
          "(N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxa",
          "mide)",
          "78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin)",
          "BJ4HF6IU1D (Pindolol)",
          "TK65WKS8HL (Buspirone)"
     ],
     "SB": "IM",
     "MH": [
          "8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology",
          "Animals",
          "Antidepressive Agents/pharmacology",
          "Autoradiography",
          "Binding, Competitive/drug effects",
          "Buspirone/pharmacology",
          "CHO Cells",
          "Cell Membrane/drug effects/metabolism",
          "Cricetinae",
          "Cricetulus",
          "Dose-Response Relationship, Drug",
          "Frontal Lobe/drug effects/metabolism",
          "Guanosine 5'-O-(3-Thiotriphosphate)/metabolism",
          "Hippocampus/drug effects/metabolism",
          "Humans",
          "Male",
          "Middle Aged",
          "Pindolol/pharmacology",
          "Piperazines/*pharmacology",
          "Pyridines/pharmacology",
          "Quinolones/*pharmacology",
          "Radioligand Assay",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptor, Serotonin, 5-HT1A/*metabolism",
          "Serotonin 5-HT1 Receptor Agonists",
          "Serotonin 5-HT1 Receptor Antagonists",
          "Serotonin Antagonists/pharmacology",
          "Serotonin Receptor Agonists/pharmacology",
          "Sulfur Radioisotopes"
     ],
     "EDAT": "2005/06/30 09:00",
     "MHDA": "2005/09/13 09:00",
     "CRDT": [
          "2005/06/30 09:00"
     ],
     "PHST": [
          "2005/05/20 00:00 [received]",
          "2005/05/24 00:00 [accepted]",
          "2005/06/30 09:00 [pubmed]",
          "2005/09/13 09:00 [medline]",
          "2005/06/30 09:00 [entrez]"
     ],
     "AID": [
          "S0014-2999(05)00569-8 [pii]",
          "10.1016/j.ejphar.2005.05.035 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 2005 Jul 11;517(3):165-73. doi: 10.1016/j.ejphar.2005.05.035.",
     "term": "hippocampus"
}